Iron deficiency anemia (IDA) is a common medical problem. In fact, 9% of women and up to 5% of men in the US have IDA.2,3 It results when the body doesn’t have enough healthy red blood cells. Iron is a building block of red blood cells, and when there isn’t enough, red blood cells cannot carry oxygen to the tissues and cells of the body as they should.4
A person develops IDA when iron stores in the body run low. This can happen for many reasons:5
- Blood is lost more quickly than it can be replaced by the body
- Iron is not absorbed as well as it should be
- The diet does not contain enough iron-rich foods
- Your need for iron is greater than usual (due to pregnancy, for example)6
Many oral iron supplements are available by prescription from your doctor or over-the-counter on pharmacy shelves. What makes Ferralet 90 different? Ferralet 90 contains Ferr-Ease®* dual-iron delivery, a biocomplementary iron formulation with 1 rapidly absorbed and 1 slowly absorbed iron.7 And because it is extremely well tolerated, unlike some other iron formulations, Ferralet 90 transforms iron therapy into a gentle experience.
1 Donovan A, Roy CN, Andrews NC. The ins and outs of iron homeostasis. Physiol (Bethesda). 2006;21:115-123.
2 Cogswell ME, Looker AC, Pfeiffer CM, et al. Assessment of iron deficiency in US preschool children and nonpregnant females of childbearing age: National Heart and Nutrition Examination Survey 2003-2006. Am J Clin Nutr. 2009;89(5):1334-1342.
3 Clark SF. Iron deficiency anemia. Nutr Clin Pract. 2008;23(2):128-141. doi:10.1177/0884533608314536.
4 Gordeuk VR, Brittenham GM, McLaren CE, Hughes MA, Keating LJ. Carbonyl iron therapy for iron deficiency anemia. Blood. 1986;67(3):745-752.
5 Iron deficiency anemia. A.D.A.M. Medical Encyclopedia Web site. http://www.nlm.nih.gov/medlineplus/ency/article/000584.htm. Updated March 22, 2013. Accessed April 5, 2013.
6 Bodnar LM, Scanlon KS, Freedman DS, Siega-Riz AM, Cogswell ME. High prevalence of postpartum anemia among low-income women in the United States. Am J Obstet Gynecol. 2001;185(2):438-443.
7 Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112(2):219-230. doi:10.1182/blood-2007-12-07738.
Ferralet 90 is available by prescription only. Please see the full Prescribing Information.
* US Patent no. 6,521,247.
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Ferralet® 90 is a prescription iron supplement indicated for the treatment of all anemias that are responsive to oral iron therapy. Your doctor may prescribe Ferralet® 90 if you have iron deficiency anemia associated with pregnancy, blood loss, or metabolic disease, or if you are recovering from surgery or do not have enough iron in your diet.
Important Safety Information
Ferralet® 90 has not been tested in children. Dosing for elderly patients should begin at the lower end of the dosing range.
Talk to your doctor before taking Ferralet® 90 if you have a known sensitivity to any of its ingredients.
Because some medications may interact with Ferralet® 90, you should tell your doctor about any medications you are taking, including antacids and antibiotics.
Before prescribing iron therapy, your doctor will need to determine the type of anemia you have and identify its underlying causes. You should not take this product if you have been diagnosed with hemolytic anemia or an iron overload disorder such as hemochromatosis or hemosiderosis.
If you have certain forms of anemia associated with vitamin B12 deficiency (i.e. pernicious anemia), the Folic acid contained in Ferralet® 90 is not enough to treat your condition. Doses of more than 0.1 mg Folic acid per day can hide the symptoms of these anemias, so your doctor must rule them out before prescribing this product.
Once you begin iron therapy with Ferralet® 90, take the product 2 hours after meals, and do not exceed the recommended dose.
When taking Ferralet® 90, you may experience temporary side effects such as GI irritation, constipation, diarrhea, nausea, vomiting, and dark stools.
Some patients taking Folic acid have reported allergic reactions. Additionally, Ferralet® 90 contains FD&C Yellow No. 5 (tartrazine), which may cause allergic reactions (including bronchial asthma) in certain susceptible people. Although uncommon, tartrazine sensitivity is often seen in patients who also have aspirin hypersensitivity. Contact your doctor and discontinue use if you develop any unusual symptoms.
Keep this product out of reach of children. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. Symptoms of overdose include abdominal pain, metabolic acidosis, decline or absence of urine production, nerve damage, coma, convulsions, death, dehydration, congestion of blood vessels, cirrhosis of the liver, low blood pressure, hypothermia, fatigue, nausea, vomiting, diarrhea, black or tarry stools, vomiting blood, rapid heart rate, high blood sugar, drowsiness, abnormal pale or bluish skin color, lack of energy, seizures, and shock. In case of accidental overdose, call a doctor or poison control center immediately.
To report negative side effects, contact Mission Pharmacal Company at 1-800-298-1087 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Ferralet® 90 is a prescription iron supplement indicated for the treatment of all anemias that are responsive to oral iron therapy. Your doctor may prescribe Ferralet® 90 if you have iron deficiency anemia associated with pregnancy, blood loss, or metabolic disease, or if you are recovering from surgery or do not have enough iron in your diet.
Important Safety Information
Ferralet® 90 has not been tested in children. Dosing for elderly patients should begin at the lower end of the dosing range.
Talk to your doctor before taking Ferralet® 90 if you have a known sensitivity to any of its ingredients.
Because some medications may interact with Ferralet® 90, you should tell your doctor about any medications you are taking, including antacids and antibiotics.
Before prescribing iron therapy, your doctor will need to determine the type of anemia you have and identify its underlying causes. You should not take this product if you have been diagnosed with hemolytic anemia or an iron overload disorder such as hemochromatosis or hemosiderosis.
If you have certain forms of anemia associated with vitamin B12 deficiency (i.e. pernicious anemia), the Folic acid contained in Ferralet® 90 is not enough to treat your condition. Doses of more than 0.1 mg Folic acid per day can hide the symptoms of these anemias, so your doctor must rule them out before prescribing this product.
Once you begin iron therapy with Ferralet® 90, take the product 2 hours after meals, and do not exceed the recommended dose.
When taking Ferralet® 90, you may experience temporary side effects such as GI irritation, constipation, diarrhea, nausea, vomiting, and dark stools.
Some patients taking Folic acid have reported allergic reactions. Additionally, Ferralet® 90 contains FD&C Yellow No. 5 (tartrazine), which may cause allergic reactions (including bronchial asthma) in certain susceptible people. Although uncommon, tartrazine sensitivity is often seen in patients who also have aspirin hypersensitivity. Contact your doctor and discontinue use if you develop any unusual symptoms.
Keep this product out of reach of children. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. Symptoms of overdose include abdominal pain, metabolic acidosis, decline or absence of urine production, nerve damage, coma, convulsions, death, dehydration, congestion of blood vessels, cirrhosis of the liver, low blood pressure, hypothermia, fatigue, nausea, vomiting, diarrhea, black or tarry stools, vomiting blood, rapid heart rate, high blood sugar, drowsiness, abnormal pale or bluish skin color, lack of energy, seizures, and shock. In case of accidental overdose, call a doctor or poison control center immediately.
To report negative side effects, contact Mission Pharmacal Company at 1-800-298-1087 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.